Health.

“Pigs are currently the generally accepted source species for xenotransplantation into humans due to their physiological similarity to humans and the ability to scale production.”

Current evidence supports pigs as the accepted source species for human xenotransplantation. The main reasons cited across reviews and clinical updates are functional organ and metabolic compatibility with humans, plus practical scalability through breeding and genetic engineering. The key caveat is that this compatibility is engineered and still faces major immune barriers, so acceptance refers to research and early clinical practice, not routine transplantation.

“There is a real, documented organ shortage crisis.”

The evidence strongly supports the existence of a persistent organ shortage. Official transplant data and peer-reviewed studies show that demand for organs continues to exceed supply, producing large waitlists and ongoing deaths among patients awaiting transplants in both the U.S. and globally. Rising transplant numbers and some improved outcomes indicate progress, not resolution of the shortage.

“In New Zealand, having fewer than 9 deceased organ donors per million people results in hundreds of patients dying each year while waiting for organ transplants.”

The claim is not supported by current New Zealand evidence. Recent official and medical sources place deceased donor rates above 9 per million in many recent years, and the available waiting-list mortality figures are far below “hundreds each year.” Patients do die waiting for transplants, but this claim overstates both the donor-rate problem and the scale of deaths.

“In 2011, there were 400 people on the transplant waiting list in New Zealand.”

The claim is directionally accurate but not exact. The strongest official evidence puts New Zealand’s organ transplant waiting list at 420 people on 31 December 2011, while other sources describe the figure more loosely as about 400 to 500. Saying “400” is a reasonable approximation, but it understates the specific official year-end count and leaves out that the list changed over time.

“Living Cell Technologies conducted clinical trials in New Zealand in which islet cells from Auckland Island pigs were transplanted into eight patients with type 1 diabetes.”

The central claim is well supported: Living Cell Technologies did conduct New Zealand clinical studies using Auckland Island pig islet cells in patients with type 1 diabetes. The problem is the number. Eight patients matches an intermediate stage reported at the time, but the completed New Zealand trial later treated 14 patients, so the claim is accurate in substance but incomplete as stated.

“Pancreatic proteases such as trypsinogen and chymotrypsinogen are synthesized as inactive zymogens and are activated in the duodenum by an intestinal enzyme (enterokinase/enteropeptidase), which helps prevent autodigestion of the pancreas.”

The claim matches standard human physiology. Pancreatic proteases are secreted as inactive precursors, and enteropeptidase in the duodenum initiates their activation by converting trypsinogen to trypsin, which then activates other zymogens. Delaying activation until the intestine is an important safeguard against pancreatic autodigestion, though not the only one.

“During emulsification in digestion, each microscopic fat droplet contains only lipids inside, bile salts form an outer coating with their hydrophobic ends facing inward and hydrophilic ends facing outward, and water surrounds the droplet outside this coating.”

The claim captures the basic textbook picture of fat emulsification, but it overstates how neat the molecular structure is. Bile salts do orient with hydrophobic regions toward lipid and hydrophilic regions toward surrounding water, so water is outside the droplet. However, real digestive droplets are not best described as a perfectly pure lipid core wrapped by a simple bile-salt shell.

“Consuming sugary drinks before midnight makes babies hyperactive and less likely to fall asleep at their usual bedtime.”

The evidence does not support this claim. Research and pediatric guidance do not show that sugar itself makes babies acutely hyperactive, and the better-supported sleep concern in sweet drinks is caffeine, not sugar alone. The claim also invents a "before midnight" cutoff and extends findings from older children or long-term observational studies to babies and same-night bedtime effects without evidence.

“Reduced perfusion of the small-intestinal mucosa can impair enterocyte renewal and contribute to villous blunting (villous atrophy), reducing absorptive surface area.”

Evidence supports this mechanism. Reduced small-intestinal mucosal perfusion can impair epithelial renewal, promote enterocyte loss, and contribute to villous blunting, which lowers absorptive surface area. The strongest data come from ischemia, shock, and sustained hypoperfusion models, but the claim is appropriately cautious in saying this can occur and can contribute.

“During an acute stress response, splanchnic vasoconstriction reduces gastrointestinal perfusion and prioritizes blood flow to the heart, lungs, and skeletal muscle.”

The statement captures the main physiology: acute sympathetic activation constricts the splanchnic circulation, lowering gastrointestinal blood flow and helping preserve perfusion for the heart and active skeletal muscle. The weak point is "lungs": pulmonary flow usually rises because cardiac output rises, not because blood is selectively diverted there. Many references also emphasize preservation of brain perfusion and arterial pressure.

“Villous blunting can reduce intestinal absorption of nutrients including glucose, amino acids, and fat-soluble vitamins.”

The evidence supports the claim. Villous blunting decreases absorptive surface and functional capacity in the small intestine, which can reduce absorption of glucose, amino acids, and fats; fat-soluble vitamin deficits commonly follow from impaired fat absorption. Severity varies by how extensive the villous damage is, but the basic statement is accurate.

“Physiologic stress can increase intestinal permeability by disrupting tight junctions between enterocytes, which increases translocation of luminal antigens and bacteria.”

The literature strongly supports that stress can impair the intestinal barrier by altering tight-junction function and increasing permeability. Reviews, animal studies, and cell studies also link this barrier disruption to greater passage of luminal antigens and, in some models, bacteria. The main caveat is that the full causal chain is demonstrated most directly in animal and in vitro research; human evidence is stronger for permeability changes than for direct bacterial translocation.

“During acute stress, pulmonary blood flow increases mainly because cardiac output increases.”

The central mechanism is correct for typical acute stress in healthy people: sympathetic activation raises cardiac output, and pulmonary blood flow usually rises with it. The statement becomes too broad if applied to all stressors or all patients, because acute hypoxia and diseases such as severe pulmonary hypertension can make pulmonary vascular resistance or right-heart afterload more important.

“After proteases finish digesting food in the duodenum, they move with chyme into the mid and distal small intestine and begin digesting themselves and other enzymes into amino acids.”

The evidence supports that pancreatic proteases continue moving with chyme beyond the duodenum and may be degraded during transit. But the claim misstates both timing and mechanism: protein digestion is not simply finished in the duodenum, and free amino acids are produced mainly through brush-border and intracellular peptidases, not primarily by proteases digesting themselves and other enzymes.

“Most intestinal juice in the small intestine comes from the contents released when small-intestinal epithelial cells rupture and slough off, rather than from fluid actively secreted by intestinal glands.”

The evidence does not support the claim. Authoritative physiology sources describe intestinal juice as mainly water and electrolytes actively secreted by crypt epithelium and glands, not fluid released from ruptured, sloughed cells. The main cited support concerns protein content in cellular debris from an older animal study, which does not establish that most intestinal juice volume comes from cell shedding.

“Under normal conditions, only a very small fraction of dietary amino acids in the small-intestinal lumen are diverted by other substances or are consumed by colonic bacteria before being absorbed, so amino-acid loss is very low.”

Most dietary amino acids are absorbed in the small intestine under normal, healthy conditions, so losses before absorption are generally low. Human studies and reviews commonly report ileal amino-acid digestibility above 90%, often above 95%. The wording is somewhat broad because digestibility differs by protein source and some proteinaceous material still reaches the colon, but that does not overturn the main conclusion for typical diets.

“In humans, taste buds that detect sweetness are concentrated at the tip of the tongue.”

The evidence does not support the idea that sweetness-detecting taste buds are concentrated at the tip of the human tongue. Modern research shows sweet receptors and taste buds are distributed across the tongue, and the classic “tongue map” is widely regarded as a myth. At most, some studies suggest slight sensitivity differences at the tip, but that is not the same as a concentration of sweet-detecting taste buds.

“Drinking coffee stains teeth yellow.”

Coffee is a well-established cause of extrinsic tooth staining, and the discoloration often appears yellow-brown over time. The evidence from dental studies is strong, but the effect is not uniform or inevitable for every coffee drinker. Staining depends on exposure, enamel condition, and oral hygiene, and some studies use lab conditions that can overstate real-world effects.

“Eating chocolate cures depression.”

The evidence does not support chocolate as a cure for depression. Some studies suggest small, short-term mood improvements from cocoa-rich products, but they do not show that eating chocolate resolves diagnosed depressive disorder or provides lasting clinical recovery. Major health authorities and systematic reviews do not endorse chocolate as a treatment for depression.

“Among patients 12 months after ST-elevation myocardial infarction, those with high-sensitivity C-reactive protein levels greater than 26.4 mg/L had a 12% rate of major adverse cardiovascular events, compared with a 4% rate among those with high-sensitivity C-reactive protein levels at or below 26.4 mg/L.”

The quoted 12% versus 4% event rates are supported by a 2024 peer-reviewed STEMI study. However, those numbers came from a selected cohort followed for about 12 months, and the 26.4 mg/L threshold was the study’s median hs-CRP level, not a broadly accepted universal cutoff. The data are accurate, but the wording is slightly broader than the underlying evidence.